• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

4 Barriers to Overcome Before AI in Medical Imaging Becomes Mainstream

by Fred Pennic 08/07/2018 Leave a Comment

The world market for artificial intelligence (AI) in medical imaging, comprising software for automated detection, quantification, decision support, and diagnosis, is forecasted to reach $2 billion by 2023, according to a new report from Signify Research, an independent supplier of market intelligence and consultancy to the global healthcare technology industry. The report, “Machine Learning in Medical Imaging – 2018 Edition” provides a data-centric and global outlook on the current and projected uptake of AI in medical imaging. The report blends primary data collected from in-depth interviews with healthcare professionals and technology vendors, to provide a balanced and objective view of the market.

Despite some of the earlier market hype, it is becoming increasingly clear that AI is destined to transform the diagnostic imaging industry, both in terms of enhanced productivity, increased diagnostic accuracy, more personalized treatment planning, and ultimately, improved clinical outcomes. AI will play a key role in enabling radiology departments to cope with the ever-increasing volume of diagnostic imaging procedures, despite the chronic shortage of radiologists in many countries.

Following the introduction of deep learning technology and affordable cloud compute (GPU) and storage, the pace of product development for AI-based medical image analysis tools is faster than ever before. Not only is this leading to increased product availability from a wider selection of vendors, but AI-based tools are gradually becoming more accurate and sophisticated with added functionalities.

The report also cited four key barriers to growth that need to be overcome before AI in medical imaging becomes mainstream :

1. The regulatory process remains challenging and there are few approved and fully commercialized products on the market, particularly deep learning-based products.

2. More large-scale validation studies are needed to show the performance of deep learning algorithms in real-world clinical settings and boost radiologist confidence in AI.

3. The results from AI-based image analysis tools need to be fully integrated into radiologists’ workflows and presented at the time of the primary read. Algorithm developers need to partner with imaging IT vendors to ensure their solutions are tightly integrated.

4. Healthcare providers are reluctant to purchase AI tools from multiple software developers due to the vendor-specific integration and implementation challenges and the administrative overhead. Algorithm developers need to establish effective routes to market, such as distribution deals with the established medical imaging vendors and the new breed of vendor-neutral AI platforms.

 

“The interest and enthusiasm for AI in the radiologist community have notably increased over the last 12 to 18 months and the discussion has moved on from AI as a threat, to how AI will augment radiologists. At the same time, there are emerging clinical applications where the use of AI has been shown to both improve clinical outcomes and deliver a return on investment for healthcare providers. Examples include software to detect and diagnose stroke and analysis tools to measure blood flow in non-invasive coronary exams,” said Signify Research analyst Simon Harris.

Harris concluded ”Up to now, the market has mainly been driven by the many start-ups and specialist software developers who are applying machine learning to medical imaging, but the major medical imaging vendors are now ramping-up their AI activities. In the last year or so, we’ve also seen several of the world’s technology giants apply their AI expertise to medical imaging, most notably China’s Tencent and Alibaba. Over the coming years, the combined R&D firepower of the expanding ecosystem will knock down the remaining barriers and radiologists will have a rapidly expanding array of AI-powered workflow and diagnostic tools at their disposal.”

 

Tagged With: AI, algorithms, Artificial Intelligence, Artificial Intelligence (AI) Software Platform, cloud, decision support, Deep Learning, Diagnostic Imaging, global healthcare, healthcare technology, Machine Learning, Medical Imaging Cloud, Radiologist, radiology, Signify Research

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Q/A: Oatmeal Health Co-Founder Talks AI-Enabled Cancer Screening for the Underserved

Q/A: Oatmeal Health Co-Founder Talks AI-Enabled Cancer Screening for the Underserved

GE HealthCare to Acquire Caption Health

GE HealthCare to Acquire Caption Health to Expand AI-Guided Ultrasounds

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |